FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Thomas Uldrick

Research Profile

Living Beings

Human Herpesvirus 8

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Highly Active Antiretroviral Therapy

Physiology

Co-author Network

Publications

TOP 3
Girish Venkataraman; Denise Whitby; Robert Yarchoan; Karen Aleman; Donald S Karcher; Richard F Little; Vickie Marshall; Deirdre O'Mahony; Stefania Pittaluga; Mark A Raffeld; Seth M Steinberg; Thomas Uldrick; Irina Maric
Bone marrow findings in HIV-positive patients with Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.
S Sakakibara; G Espigol-Frigole; P Gasperini; Thomas Uldrick; Robert Yarchoan; Giovanna Tosato
A20/TNFAIP3 inhibits NF-κB activation induced by the Kaposi's sarcoma-associated herpesvirus vFLIP oncoprotein.
Thomas Uldrick; Mark N Polizzotto; Robert Yarchoan
Recent advances in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Thomas Uldrick (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Girish Venkataraman; Denise Whitby; Robert Yarchoan; Karen Aleman; Donald S Karcher; Richard F Little; Vickie Marshall; Deirdre O'Mahony; Stefania Pittaluga; Mark A Raffeld; Seth M Steinberg; Thomas Uldrick; Irina Maric
Bone marrow findings in HIV-positive patients with Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.
American journal of clinical pathology 2013;139(5):651-61.
2013: S Sakakibara; G Espigol-Frigole; P Gasperini; Thomas Uldrick; Robert Yarchoan; Giovanna Tosato
A20/TNFAIP3 inhibits NF-κB activation induced by the Kaposi's sarcoma-associated herpesvirus vFLIP oncoprotein.
Oncogene 2013;32(10):1223-32.
2012: Thomas Uldrick; Mark N Polizzotto; Robert Yarchoan
Recent advances in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.
Current opinion in oncology 2012;24(5):495-505.
2012: Thomas Uldrick; Denise Whitby; Kathleen M Wyvill; Karen Aleman; Wendy Bernstein; PALLAVI KUMAR; Richard F Little; Vickie Marshall; Deirdre O'Mahony; Stefania Pittaluga; Mark N Polizzotto; Seth M Steinberg; Robert Yarchoan
Phase II study of bevacizumab in patients with HIV-associated Kaposi's sarcoma receiving antiretroviral therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(13):1476-83.
2012: Paola Gasperini; Dragan Maric; Peter J McCormick; Mark N Polizzotto; Ombretta Salvucci; Thomas Uldrick; Robert Yarchoan; Georgina Espigol-Frigole; Giovanna Tosato
Kaposi sarcoma herpesvirus promotes endothelial-to-mesenchymal transition through Notch-dependent signaling.
Cancer research 2012;72(5):1157-69.
2012: Mark N Polizzotto; Thomas Uldrick; Duosha Hu; Robert Yarchoan
Clinical Manifestations of Kaposi Sarcoma Herpesvirus Lytic Activation: Multicentric Castleman Disease (KSHV-MCD) and the KSHV Inflammatory Cytokine Syndrome.
Frontiers in microbiology 2012;3():73.
2011: Ju-Gyeong Kang; Michael J Kruhlak; Vladimir Majerciak; Thomas Uldrick; Xiaohong Wang; Robert Yarchoan; Zhi-Ming Zheng
Kaposi's sarcoma-associated herpesviral IL-6 and human IL-6 open reading frames contain miRNA binding sites and are subject to cellular miRNA regulation.
The Journal of pathology 2011;225(3):378-89.
2011: Thomas Uldrick; Victoria Wang; Denise Whitby; Kathleen M Wyvill; Karen Aleman; Richard F Little; Vickie Marshall; Deirdre O'Mahony; Stefania Pittaluga; Mark N Polizzotto; Seth M Steinberg; Giovanna Tosato; Robert Yarchoan
High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy.
Blood 2011;117(26):6977-86.
2011: Thomas Uldrick; Denise Whitby
Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma.
Cancer letters 2011;305(2):150-62.
2011: Meredith S Shiels; Ruth M Pfeiffer; Mitchell H Gail; H Irene Hall; J Li; Anil K Chaturvedi; Kishor Bhatia; Thomas Uldrick; Robert Yarchoan; James J Goedert; Eric A Engels
Cancer burden in the HIV-infected population in the United States.
Journal of the National Cancer Institute 2011;103(9):753-62.
2010: Johanna R Abend; Thomas Uldrick; Joseph M Ziegelbauer
Regulation of tumor necrosis factor-like weak inducer of apoptosis receptor protein (TWEAKR) expression by Kaposi's sarcoma-associated herpesvirus microRNA prevents TWEAK-induced apoptosis and inflammatory cytokine expression.
Journal of virology 2010;84(23):12139-51.
2010: Thomas Uldrick; Victoria Wang; Deirdre O'Mahony; Karen Aleman; Kathleen M Wyvill; Vickie Marshall; Seth M Steinberg; Stefania Pittaluga; Irina Maric; Denise Whitby; Giovanna Tosato; Richard F Little; Robert Yarchoan
An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010;51(3):350-8.
2009: Anisa Mosam; H Carrara; F Shaik; Thomas Uldrick; A Berkman; Jamila Aboobaker; Hoosen M Coovadia
Increasing incidence of Kaposi's sarcoma in black South Africans in KwaZulu-Natal, South Africa (1983-2006).
International journal of STD & AIDS 2009;20(8):553-6.
2006: Michio Hirano; Ramon Martí; C Casali; Saba Tadesse; Thomas Uldrick; B Fine; Diana Escolar; Maria Lucia Valentino; Ichizo Nishino; Charles Hesdorffer; Joseph Schwartz; Ria Hawks; D L Martone; Mitchell S Cairo; Salvatore DiMauro; M Stanzani; JH Garvin; David G Savage
Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE.
Neurology 2006;67(8):1458-60.